awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38821464-3F2F5700-0413-4814-9D86-51316C3B6BAE
Q38821464-3F2F5700-0413-4814-9D86-51316C3B6BAE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38821464-3F2F5700-0413-4814-9D86-51316C3B6BAE
Sodium-glucose co-transporter 2 inhibitors for type 2 diabetes mellitus: An overview for the primary care physician.
P2860
Q38821464-3F2F5700-0413-4814-9D86-51316C3B6BAE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38821464-3F2F5700-0413-4814-9D86-51316C3B6BAE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
09c32bde98fffc86c72ec9ceaf42c13c485d8df9
P2860
Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control.